Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on: April 28,2024

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on:April 28,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on: January 26,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on:January 26,2024

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi

Updated on: February 20,2024

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi

Updated on:February 20,2024

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on: December 25,2023

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on:December 25,2023

Newly developed mathematical model could be used to predict cancer drug side effects in individuals

byKobe UniversityA bar graph to show drug metabolism predictions for the anti-cancer agent Irinotecan (the gray bars are the predictions and the black bars are the actual results). The shorter t

Updated on: December 22,2023

Newly developed mathematical model could be used to predict cancer drug side effects in individuals

byKobe UniversityA bar graph to show drug metabolism predictions for the anti-cancer agent Irinotecan (the gray bars are the predictions and the black bars are the actual results). The shorter t

Updated on:December 22,2023

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on: January 23,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on:January 23,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on: January 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on:January 08,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on: January 10,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on:January 10,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on: July 08,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on:July 08,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on: June 28,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on:June 28,2024

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Updated on: July 09,2024

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Updated on:July 09,2024